镰状细胞病与早产的发生率及病因
美国杜克大学医院2013至2020年回顾性队列研究,66例镰状细胞病孕妇中早产占39.4%,显著高于全院人口的14.1%(风险比2.79)。早产中69.2%为医学指征性,高于美国黑人参考人群的34.6%,医学指征性早产风险为后者的2.00倍。
要点
- 镰状细胞病孕妇早产风险约为杜克医院总体人群的2.79倍。
- 镰状细胞病孕妇早产中医学指征性占69.2%,高于美国黑人人群的34.6%。
- 医学指征性早产风险约为美国黑人参考人群的2.00倍。
核心结论
- 母亲镰状细胞病使早产风险接近三倍,且医学指征性早产风险约为两倍。
研究设计与样本
- 回顾性、机构审查委员会豁免的队列研究,纳入杜克大学医院2013至2020年妊娠>20周的镰状细胞病分娩。
- 筛查镰状细胞病相关住院373例,排除妊娠<20周、多胎妊娠或未经证实的镰状细胞病,最终纳入杜克院内分娩66例。
- 将镰状细胞病队列与杜克总体人群(n=18,365)及早产中自发与医学指征比例与美国种族匹配人群比较。
主要发现
- 66例妊娠中65例(98.5%)自述为黑人。
- 镰状细胞病队列早产39.4%(n=26) vs 杜克总体人群早产14.1%(n=2594),风险比2.79(95%CI 2.06-3.77,P<.001)。
- 镰状细胞病队列26例早产中自发30.8%(n=8)、医学指征69.2%(n=18);美国黑人参考队列早产中自发65.4%(n=392,984)、医学指征34.6%(n=207,614)。
- 镰状细胞病队列医学指征性早产风险为美国参考人群的2.00倍(风险比2.00,95%CI 1.55-2.59,P<.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Medically indicated delivery can be defined as delivery owing to intervention for maternal or fetal well-being-most commonly because of preeclampsia or nonreassuring fetal status. Among the general population of the United States, approximately two-thirds of preterm deliveries are because of spontaneous labor and/or premature rupture of membranes, whereas the remaining one-third are medically indicated. Despite the increased risk of preterm birth among women with sickle cell disease, the specific etiologies have not been described in the medical literature. Without an understanding of the etiologies of preterm birth in women with sickle cell disease, it is difficult to develop preventative strategies. OBJECTIVE: This study aimed to estimate the incidence and etiologies of preterm births (spontaneous vs medically indicated) in women with sickle cell disease. STUDY DESIGN: This was a retrospective, institutional review board-exempt cohort study of deliveries at >20 weeks' gestation in women with sickle cell disease at Duke University Hospital (2013-2020). We screened pregnancy-linked hospitalizations with International Classification of Diseases-9/10 codes for sickle cell disease (n=373). We excluded cases of pregnancy with <20 weeks' gestation, multiple gestation, or unproven sickle cell disease. We limited inclusion to deliveries within Duke (n=66). We compared the proportion of preterm birth cases between the sickle cell disease cohort and the overall Duke population (n=18,365), and the proportion of spontaneous vs medically indicated preterm births between the sickle cell disease cohort and a racially matched US population. RESULTS: Of the 66 pregnancies, 65 occurred in patients who self-described as Black (98.5%). There were 60.6% (n=40) term and 39.4% (n=26) preterm births vs 85.9% term (n=15,771) and 14.1% preterm (n=2594) births in the Duke population as a whole. The sickle cell disease cohort was nearly 3 times more likely to deliver preterm than the Duke cohort (risk ratio, 2.79; 95% confidence interval, 2.06-3.77; P<.001). Among the 26 preterm births in the sickle cell disease cohort, 30.8% (n=8) were spontaneous and 69.2% (n=18) were medically indicated. In the US Black population comparison cohort, 65.4% (n=392,984) of preterm births were spontaneous and 34.6% (n=207,614) were medically indicated. The sickle cell disease cohort had 2 times the risk of medically indicated preterm birth compared with the US population cohort (risk ratio, 2.00; 95% confidence interval, 1.55-2.59; P<.001). CONCLUSION: Maternal sickle cell disease confers nearly triple the risk of preterm birth, which is twice as likely to be medically indicated.
引用
- Fashakin V, Weber JM, Truong T, et al. Sickle cell disease and the incidence and etiology of preterm birth. Am J Obstet Gynecol MFM. 2022. PMID: 35995364. doi:10.1016/j.ajogmf.2022.100723
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。